Exousia Bio (LMMY) Other Operating Expenses (2024 - 2026)

Exousia Bio (LMMY) has 3 years of Other Operating Expenses data on file, last reported at $13471.0 in Q1 2026.

• Quarterly Other Operating Expenses changed N/A year-over-year to $13471.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $62219.0 (up 1793.03% YoY) and the FY2025 annual result came in at $3463.0, changed N/A from the prior year.
• Other Operating Expenses was little changed at $13471.0 in Q1 2026 per LMMY's latest filing, from $13471.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $31814.0 in Q3 2025, with the low at -$3675.0 in Q3 2024.
• Average Other Operating Expenses over 3 years is $11708.8, with a median of $13471.0 recorded in 2025.
• The widest YoY moves for Other Operating Expenses: up 965.69% in 2025, down 965.69% in 2025.
• Exousia Bio's Other Operating Expenses stood at -$3675.0 in 2024, then surged by 466.56% to $13471.0 in 2025, then changed by 0.0% to $13471.0 in 2026.
• Business Quant data shows LMMY's Other Operating Expenses at $13471.0 in Q1 2026, $13471.0 in Q4 2025, and $31814.0 in Q3 2025.